1 hour ago
The rheumatology month in review emphasizes new research in RA burden, fibromyalgia treatment, and insights from the EULAR 2025 meeting.
5 hours ago
This month in review captures 5 allergy news in June, from FDA approvals to phase 3 data.
7 hours ago
The month in review spotlights hepatic regulatory news, new clinical trial data, and novel research about liver disease risk factors.
8 hours ago
Our Q2 2025 recap for ophthalmology highlights 5 regulatory updates, 5 important trial announcements, and top perspectives in eyecare.
9 hours ago
June 2025 saw more research emerge in asthma therapeutics and management as well as rarer pulmonary diseases.